Search
Racementhol
go.drugbank.com/drugs/DB14123ApprovedInvestigationalMixtures: Nan San MUSFLEX External Analgesic, Nan San MUSFLEX External AnalgesicProducts: SANA SANA Menthol External Analgesic, Nan San EASY FLEX Pain RelievingFamtozinameran
go.drugbank.com/drugs/DB17088ApprovedInvestigationalThe Omicron variant of SARS-CoV-2 is a variant of concern that was first reported in November 2021. … [L43917] Famtozinameran is an mRNA vaccine encoding the S glycoprotein of SARS-CoV-2 Omicron variant lineages BA.4 and BA.5.
Casirivimab
go.drugbank.com/drugs/DB15941ApprovedInvestigational[A224429] These antibodies have been formulated to bind to multiple locations on the SARS-COV-2 spike protein, preventing viral escape.
Ensitrelvir
go.drugbank.com/drugs/DB18834ApprovedInvestigationalEnsitrelvir is an oral small-molecule antiviral that inhibits the SARS-CoV-2 main protease (Mpro, also known as 3CLpro), an enzyme the virus needs to replicate. … [A286912, L63347] Ensitrelvir was first approved in Japan, receiving emergency regulatory approval in November 2022 and standard approval on 5 March 2024 for the treatment of SARS-CoV-2 infection.
Nirmatrelvir
go.drugbank.com/drugs/DB16691ApprovedInvestigational[L33354] 3CL<sup>PRO</sup> is responsible for cleaving polyproteins 1a and 1ab of SARS-CoV-2. … [A234224,A234229,A234234] In 2020, Pfizer was investigating another potential treatment for SARS-CoV-2, [PF-07304814].
Zapomeran
go.drugbank.com/drugs/DB21761ApprovedZapomeran, marketed under the brand name Kostaive (ARCT-154), is a self-amplifying mRNA COVID-19 vaccine for individuals 18 years and older. The self-amplifying nature of the vaccine is due to the mRNA additionally encoding a replicase e...
Tramadol
go.drugbank.com/drugs/DB00193ApprovedInvestigationalTramadol is a centrally acting synthetic opioid analgesic and SNRI (serotonin/norepinephrine reuptake-inhibitor) that is structurally related to codeine and morphine. Due to its good tolerability profile and multimodal mechanism of actio...
Products: TRAMADOL-SAND 100MG/ML TROTucatinib
go.drugbank.com/drugs/DB11652ApprovedInvestigationalTucatinib is an oral tyrosine kinase inhibitor of HER2 used to treat HER2-positive breast cancer and RAS wild-type, HER2-positive colorectal cancer. Tucatinib has had initial U.S. FDA approval since 2020. The FDA-approved labeling revise...
Regdanvimab
go.drugbank.com/drugs/DB16405ApprovedWithdrawnRegdanvimab (CT-P59) is a recombinant human IgG1 monoclonal antibody directed at the receptor binding domain (RBD) of the SARS-CoV-2 spike protein.